[go: up one dir, main page]

Ye et al., 2013 - Google Patents

Electrophysiological subtypes and prognosis of Guillain–Barré syndrome in Northeastern China

Ye et al., 2013

Document ID
4374198510590300283
Author
Ye Y
Wang K
Deng F
Xing Y
Publication year
Publication venue
Muscle & nerve

External Links

Snippet

Introduction: The purpose of this study was to assess the electrophysiological subtypes and prognosis of Guillain–Barré syndrome (GBS) in northeastern China. Methods: Ninety‐nine patients with GBS were recruited between 2006 and 2010 and retrospectively reviewed …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders

Similar Documents

Publication Publication Date Title
Ye et al. Electrophysiological subtypes and prognosis of Guillain–Barré syndrome in Northeastern China
Ogrodnik et al. Whole‐body senescent cell clearance alleviates age‐related brain inflammation and cognitive impairment in mice
Anderson et al. Plasma-borne indicators of inflammasome activity in Parkinson’s disease patients
Sargin et al. Relationship between neutrophil‐lymphocyte, platelet‐lymphocyte ratio and disease activity in rheumatoid arthritis treated with rituximab
Vallat et al. Diagnostic value of nerve biopsy for atypical chronic inflammatory demyelinating polyneuropathy: evaluation of eight cases
Casciola-Rosen et al. Myositis autoantibodies
Kayahan et al. Obsessive‐compulsive symptoms in schizophrenia: Prevalance and clinical correlates
Ren et al. Blood substitution therapy rescues the brain of mice from ischemic damage
Herniman et al. Depressive psychopathology in first-episode schizophrenia spectrum disorders: a systematic review, meta-analysis and meta-regression
Chase et al. The value of interleukin 6 as a peripheral diagnostic marker in schizophrenia
Capasso et al. Involvement of sensory fibres in axonal subtypes of Guillain–Barré syndrome
Hiraga et al. Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain–Barré syndrome
Saito et al. Blood–brain barrier destruction determines Fisher/Bickerstaff clinical phenotypes: an in vitro study
Bigalke et al. Expression of platelet glycoprotein VI is associated with transient ischemic attack and stroke
Kerasnoudis et al. Bochum ultrasound score versus clinical and electrophysiological parameters in distinguishing acute‐onset chronic from acute inflammatory demyelinating polyneuropathy
Overell et al. Recent developments in Miller Fisher syndrome and related disorders
Axelsson et al. Neurofilament light protein levels in cerebrospinal fluid predict long‐term disability of Guillain‐Barré syndrome: a pilot study
Rauer et al. Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating event
Tomimitsu et al. Mechanism of action of voltage‐gated K+ channel antibodies in acquired neuromyotonia
Kuwabara et al. The refractory period of transmission is impaired in axonal Guillain–Barré syndrome
Li et al. Identification of dyslipidemia as a risk factor for sudden sensorineural hearing loss: A multicenter case‐control study
Tomasiak‐Lozowska et al. Asthma is associated with reduced fibrinolytic activity, abnormal clot architecture, and decreased clot retraction rate
Ohyama et al. Muscle atrophy in chronic inflammatory demyelinating polyneuropathy: a computed tomography assessment
Jahan et al. Neutrophil‐lymphocyte ratio in Guillain‐Barré syndrome: a prognostic biomarker of severe disease and mechanical ventilation in Bangladesh
Fountoulakis et al. One-year outcome of first vs. later episode schizophrenia: a real-world naturalistic study